Clinical Trial Update: Nicotinamide Riboside Clinical Trial for GWI [NA]

View source ↗

Summary

An ongoing clinical trial is evaluating nicotinamide riboside for Gulf War Illness and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gulf War Illness

Drugs mentioned

• Niagen®+ (nicotinamide riboside)

Snippet

Sponsor: Roskamp Institute Inc. | Conditions: Gulf War Illness | NA | Status: RECRUITING